Spark Biomedical News

EY Entrepreneur Of The Year® 2024 Southwest Award FinalistRead MoreRead More
Pathway to Cures Announces Venture Investment in Five LitersRead MoreRead More
Spark Biomedical Awarded $1.15M Department of Defense Phase II STTR Grant Read MoreRead More
Spark Biomedical Launches Telehealth Services for Sparrow Ascent, Improving Patient Access to Opioid Withdrawal TreatmentRead MoreRead More
Spark Biomedical’s second-generation device, Sparrow® Ascent, Receives FDA Clearance for Opioid Withdrawal Relief in AdultsRead MoreRead More
WBAL TV Sparrow Therapy CoverageRead MoreRead More
WCIV News Covers tANdem Clinical TrialRead MoreRead More
Clinical trial to test wearable device as treatment for chronic pain, opioid withdrawalRead MoreRead More
Feinstein Institutes for Medical Research and Spark Biomedical, Inc. advance bioelectric medicine designed to stem excessive blood lossRead MoreRead More
Spark Biomedical and Velentium Honored by Fast Company as a 2022 World Changing Idea for Their Partnership in Developing the Sparrow Therapy System™Read MoreRead More
Download the Updated Clinical Trial Whitepaper
Download Today